MONO, ORM1, ORM2, and AGP levels show excellent diagnostic value for psoriasis identification in a retrospective case-control study.
This retrospective case-control study assessed the diagnostic utility of MONO, ORM1, ORM2, and AGP levels for identifying psoriasis. The population comprised 140 participants, consisting of 70 patients with psoriasis confirmed by the dermatology department and 70 healthy individuals undergoing routine health examinations. The setting included both the dermatology department and routine health examination contexts. No follow-up duration was reported for this study.
The primary outcome measured the overall predictive ability of the model, which was described as excellent with an AUC of 0.888 (95% CI: 0.835–0.941). Individual biomarker performance varied: ORM2 showed an AUC of 0.777, ORM1 an AUC of 0.720, AGP an AUC of 0.673, and MONO an AUC of 0.638. Specific p-values or confidence intervals were not reported for the individual biomarkers.
Safety and tolerability data were not reported, as were adverse events, serious adverse events, or discontinuations. Funding or conflicts of interest were not reported. The study limitations include its retrospective case-control design, which precludes causal inference, and the absence of reported follow-up or safety monitoring. Practice relevance notes that these research results should be applied to clinical settings with appropriate caution.